CHRONIC HEP B
Clinical trials for CHRONIC HEP B explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEP B trials appear
Sign up with your email to follow new studies for CHRONIC HEP B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hepatitis b: experimental drug Tune-401 enters human testing
Disease control Recruiting nowThis early-stage study tests the safety of a new drug, Tune-401, in 36 adults with chronic hepatitis B. Participants must already be on standard antiviral therapy. The main goal is to see if the drug is safe and how the body processes it. This is not a cure, but a step toward bet…
Matched conditions: CHRONIC HEP B
Phase: PHASE1 • Sponsor: Tune Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 05:28 UTC
-
5,000 hepatitis b patients enrolled to unlock immune secrets over time
Knowledge-focused Recruiting nowThis observational study follows 5,000 untreated chronic hepatitis B patients aged 1 to 80 for years. Researchers will test blood every six months to see how the immune system changes as the disease progresses. The goal is to understand the role of age and immune response in the …
Matched conditions: CHRONIC HEP B
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:49 UTC